JPH01132511A - Hair tonic cosmetic - Google Patents
Hair tonic cosmeticInfo
- Publication number
- JPH01132511A JPH01132511A JP29084987A JP29084987A JPH01132511A JP H01132511 A JPH01132511 A JP H01132511A JP 29084987 A JP29084987 A JP 29084987A JP 29084987 A JP29084987 A JP 29084987A JP H01132511 A JPH01132511 A JP H01132511A
- Authority
- JP
- Japan
- Prior art keywords
- chain length
- hair
- carbon chain
- hair tonic
- ingredient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002537 cosmetic Substances 0.000 title abstract description 18
- 230000001256 tonic effect Effects 0.000 title abstract description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical group [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims abstract description 28
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 12
- 229930195729 fatty acid Natural products 0.000 claims abstract description 12
- 239000000194 fatty acid Substances 0.000 claims abstract description 12
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 11
- 239000003093 cationic surfactant Substances 0.000 claims abstract description 7
- 239000010696 ester oil Substances 0.000 claims abstract description 7
- 239000007788 liquid Substances 0.000 claims abstract description 7
- 230000000694 effects Effects 0.000 abstract description 20
- 239000004615 ingredient Substances 0.000 abstract description 9
- 238000002156 mixing Methods 0.000 abstract description 5
- VBIIFPGSPJYLRR-UHFFFAOYSA-M Stearyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[N+](C)(C)C VBIIFPGSPJYLRR-UHFFFAOYSA-M 0.000 abstract description 2
- YAQXGBBDJYBXKL-UHFFFAOYSA-N iron(2+);1,10-phenanthroline;dicyanide Chemical compound [Fe+2].N#[C-].N#[C-].C1=CN=C2C3=NC=CC=C3C=CC2=C1.C1=CN=C2C3=NC=CC=C3C=CC2=C1 YAQXGBBDJYBXKL-UHFFFAOYSA-N 0.000 abstract description 2
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 abstract description 2
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 abstract 1
- 238000004321 preservation Methods 0.000 abstract 1
- 125000000962 organic group Chemical group 0.000 description 25
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 14
- 230000003779 hair growth Effects 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 7
- 125000004432 carbon atom Chemical group C* 0.000 description 7
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 6
- 239000004359 castor oil Substances 0.000 description 6
- 235000019438 castor oil Nutrition 0.000 description 6
- 150000001875 compounds Chemical class 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 238000009472 formulation Methods 0.000 description 6
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 239000004480 active ingredient Substances 0.000 description 5
- -1 for example Substances 0.000 description 5
- HZAXFHJVJLSVMW-UHFFFAOYSA-N 2-Aminoethan-1-ol Chemical group NCCO HZAXFHJVJLSVMW-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000004820 halides Chemical class 0.000 description 4
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 4
- 229940105132 myristate Drugs 0.000 description 4
- TUNFSRHWOTWDNC-UHFFFAOYSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- 230000002411 adverse Effects 0.000 description 3
- 230000002776 aggregation Effects 0.000 description 3
- 238000004220 aggregation Methods 0.000 description 3
- 150000001412 amines Chemical group 0.000 description 3
- 125000004429 atom Chemical group 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 239000003205 fragrance Substances 0.000 description 3
- 229940075507 glyceryl monostearate Drugs 0.000 description 3
- 239000002736 nonionic surfactant Substances 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 238000000926 separation method Methods 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 230000003797 telogen phase Effects 0.000 description 3
- 235000015961 tonic Nutrition 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical group CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 2
- KDCGOANMDULRCW-UHFFFAOYSA-N 7H-purine Chemical compound N1=CNC2=NC=NC2=C1 KDCGOANMDULRCW-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- KIWBPDUYBMNFTB-UHFFFAOYSA-N Ethyl hydrogen sulfate Chemical group CCOS(O)(=O)=O KIWBPDUYBMNFTB-UHFFFAOYSA-N 0.000 description 2
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- 208000000474 Poliomyelitis Diseases 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 150000001408 amides Chemical class 0.000 description 2
- 235000001014 amino acid Nutrition 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical group C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000004945 emulsification Methods 0.000 description 2
- 239000003623 enhancer Substances 0.000 description 2
- 238000011156 evaluation Methods 0.000 description 2
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 2
- 229940088597 hormone Drugs 0.000 description 2
- 239000005556 hormone Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 229960000367 inositol Drugs 0.000 description 2
- 239000003410 keratolytic agent Substances 0.000 description 2
- 229940041616 menthol Drugs 0.000 description 2
- ISYWECDDZWTKFF-UHFFFAOYSA-N nonadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCCC(O)=O ISYWECDDZWTKFF-UHFFFAOYSA-N 0.000 description 2
- FBUKVWPVBMHYJY-UHFFFAOYSA-N nonanoic acid Chemical compound CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 2
- MWMPEAHGUXCSMY-UHFFFAOYSA-N pentacosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCC(O)=O MWMPEAHGUXCSMY-UHFFFAOYSA-N 0.000 description 2
- 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- XEZVDURJDFGERA-UHFFFAOYSA-N tricosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCCC(O)=O XEZVDURJDFGERA-UHFFFAOYSA-N 0.000 description 2
- SZHOJFHSIKHZHA-UHFFFAOYSA-N tridecanoic acid Chemical compound CCCCCCCCCCCCC(O)=O SZHOJFHSIKHZHA-UHFFFAOYSA-N 0.000 description 2
- ZDPHROOEEOARMN-UHFFFAOYSA-N undecanoic acid Chemical compound CCCCCCCCCCC(O)=O ZDPHROOEEOARMN-UHFFFAOYSA-N 0.000 description 2
- 229940124549 vasodilator Drugs 0.000 description 2
- 239000003071 vasodilator agent Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- JNYAEWCLZODPBN-JGWLITMVSA-N (2r,3r,4s)-2-[(1r)-1,2-dihydroxyethyl]oxolane-3,4-diol Chemical group OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O JNYAEWCLZODPBN-JGWLITMVSA-N 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N (R)-alpha-Tocopherol Natural products OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
- DDMOUSALMHHKOS-UHFFFAOYSA-N 1,2-dichloro-1,1,2,2-tetrafluoroethane Chemical compound FC(F)(Cl)C(F)(F)Cl DDMOUSALMHHKOS-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-UHFFFAOYSA-N 17alpha-ethynyl estradiol Natural products OC1=CC=C2C3CCC(C)(C(CC4)(O)C#C)C4C3CCC2=C1 BFPYWIDHMRZLRN-UHFFFAOYSA-N 0.000 description 1
- VOXZDWNPVJITMN-ZBRFXRBCSA-N 17β-estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 VOXZDWNPVJITMN-ZBRFXRBCSA-N 0.000 description 1
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 1
- QTWJRLJHJPIABL-UHFFFAOYSA-N 2-methylphenol;3-methylphenol;4-methylphenol Chemical compound CC1=CC=C(O)C=C1.CC1=CC=CC(O)=C1.CC1=CC=CC=C1O QTWJRLJHJPIABL-UHFFFAOYSA-N 0.000 description 1
- GXJLQJFVFMCVHG-QXMHVHEDSA-N 2-methylpropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)C GXJLQJFVFMCVHG-QXMHVHEDSA-N 0.000 description 1
- PHUSOTFVZQDLMC-QXMHVHEDSA-N 3-methylbutyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCCC(C)C PHUSOTFVZQDLMC-QXMHVHEDSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000228212 Aspergillus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical compound C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 description 1
- BFPYWIDHMRZLRN-SLHNCBLASA-N Ethinyl estradiol Chemical compound OC1=CC=C2[C@H]3CC[C@](C)([C@](CC4)(O)C#C)[C@@H]4[C@@H]3CCC2=C1 BFPYWIDHMRZLRN-SLHNCBLASA-N 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 125000000218 acetic acid group Chemical group C(C)(=O)* 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 125000003158 alcohol group Chemical group 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- 229940087168 alpha tocopherol Drugs 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 229940053200 antiepileptics fatty acid derivative Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- YSJGOMATDFSEED-UHFFFAOYSA-M behentrimonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCCCCCC[N+](C)(C)C YSJGOMATDFSEED-UHFFFAOYSA-M 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- TTWQNMGZIZBCEE-UHFFFAOYSA-N benzyl(octadecyl)azanium;chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCCCC[NH2+]CC1=CC=CC=C1 TTWQNMGZIZBCEE-UHFFFAOYSA-N 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- WOWHHFRSBJGXCM-UHFFFAOYSA-M cetyltrimethylammonium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+](C)(C)C WOWHHFRSBJGXCM-UHFFFAOYSA-M 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 235000019961 diglycerides of fatty acid Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- ZQPPMHVWECSIRJ-MDZDMXLPSA-M elaidate Chemical compound CCCCCCCC\C=C\CCCCCCCC([O-])=O ZQPPMHVWECSIRJ-MDZDMXLPSA-M 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- 229930182833 estradiol Natural products 0.000 description 1
- 229960005309 estradiol Drugs 0.000 description 1
- 229960002568 ethinylestradiol Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N glycerol group Chemical group OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- FUZZWVXGSFPDMH-UHFFFAOYSA-M hexanoate Chemical compound CCCCCC([O-])=O FUZZWVXGSFPDMH-UHFFFAOYSA-M 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical group O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000016507 interphase Effects 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 230000008099 melanin synthesis Effects 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 125000005527 methyl sulfate group Chemical group 0.000 description 1
- 238000011587 new zealand white rabbit Methods 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- WWZKQHOCKIZLMA-UHFFFAOYSA-M octanoate Chemical compound CCCCCCCC([O-])=O WWZKQHOCKIZLMA-UHFFFAOYSA-M 0.000 description 1
- 125000002347 octyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000014593 oils and fats Nutrition 0.000 description 1
- 229940049964 oleate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical group CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical group 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- WBHHMMIMDMUBKC-QJWNTBNXSA-M ricinoleate Chemical compound CCCCCC[C@@H](O)C\C=C/CCCCCCCC([O-])=O WBHHMMIMDMUBKC-QJWNTBNXSA-M 0.000 description 1
- 229940066675 ricinoleate Drugs 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 230000004215 skin function Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000011550 stock solution Substances 0.000 description 1
- 125000001424 substituent group Chemical group 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 125000000185 sucrose group Chemical group 0.000 description 1
- 150000005846 sugar alcohols Polymers 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L sulfate group Chemical group S(=O)(=O)([O-])[O-] QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 229960000984 tocofersolan Drugs 0.000 description 1
- 150000003626 triacylglycerols Chemical class 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
Abstract
Description
【発明の詳細な説明】 〔産業上の利用分野コ 本発明は、乳化タイプの養毛化粧料に関する。[Detailed description of the invention] [Industrial application fields] The present invention relates to an emulsion type hair nourishing cosmetic.
[従来の技術]
従来から、養毛、育毛効果が期待される各種の薬効剤を
配合した養毛剤が知らnており、脱毛症の予防及び治療
に用いられている。薬効剤としては、例えばビタミンE
などのビタミン類;セリン、メチオニンなどのアミノ酸
類;アセチルコロン誘導体などの血管拡張剤;紫根エキ
スなどの抗炎症剤;エストラジオールなどの女性ホルモ
ン剤;セファランチンなどの皮膚機能昂進剤;・Iント
テン酸銅などのメラニン合成触媒剤:セリチル酸などの
角質溶解剤などがある。[Prior Art] Hair tonics containing various medicinal agents that are expected to have hair nourishing and hair growth effects have been known, and are used for the prevention and treatment of alopecia. As a medicinal agent, for example, vitamin E
Vitamins such as; amino acids such as serine and methionine; vasodilators such as acetyl colon derivatives; anti-inflammatory agents such as purple root extract; female hormones such as estradiol; skin function enhancers such as cephalanthine; copper I-tothenate Melanin synthesis catalysts such as: Keratolytic agents such as cericylic acid.
養毛効果を有する析しい薬効成分として、奇数炭素鎖長
を有する脂肪酸又はその誘導体が見出され、そnらを有
効成分とする養毛剤が提案されている(特開昭59−2
7809)。また、脂肪酸及びその誘導体の乳化技術に
ついては、古くから研究さnており、既に公知である。Fatty acids with odd carbon chain lengths or their derivatives have been discovered as effective medicinal ingredients that have a hair-restoring effect, and hair-restoring agents containing these as active ingredients have been proposed (Japanese Patent Laid-Open No. 59-2
7809). Furthermore, emulsification techniques for fatty acids and their derivatives have been studied for a long time and are already known.
しかし、乳化タイプの養毛剤は、透明液状の本のと比べ
て有効成分の経皮吸収性は低いと言われている。また、
有効成分の化学構造によっては、低温で凝集または分離
するという不都合を生じ、そのため養毛効果が更に低下
することが懸念される。乳化タイプの養毛剤は、商品価
値上、冬期における一5℃程度における低温から真夏に
おける40°0又はそれ以上の高温下での保管条件にお
いても凝集又は分離を生じないことが必要である。しか
し、従来公知の乳化タイプの養毛剤は、これらの点で未
だ不充分であった。However, it is said that the transdermal absorption of the active ingredients in emulsified hair tonics is lower than that in transparent liquid books. Also,
Depending on the chemical structure of the active ingredient, it may cause the inconvenience of aggregation or separation at low temperatures, which may further reduce the hair-nourishing effect. For commercial value, emulsified type hair nourishing agents must not cause aggregation or separation even under storage conditions ranging from a low temperature of about 15° C. in winter to a high temperature of 40° C. or more in midsummer. However, conventionally known emulsion type hair nourishing agents are still insufficient in these respects.
[発明が解決しようとする問題点]
本発明は、上記事情に鑑みなされたものであって、優れ
た養毛効果を有するとともに、低温保存性において著し
く改良された乳化タイプの養毛剤組成物を提供すること
を目的とする。[Problems to be Solved by the Invention] The present invention has been made in view of the above circumstances, and provides an emulsion type hair growth composition that has an excellent hair growth effect and is significantly improved in low-temperature storage stability. The purpose is to
本発明者らは、上記目的を達成するため鋭意研究を重ね
た結果、奇数炭素鎖長を有する脂肪酸又はその所定の誘
導体と、所定のカチオン界面活性剤と、所定の非イオン
界面活性剤と、所定のエステル油とを組合せることによ
シ、優nた養毛効果を有するとともに、低温における保
存安定性が大幅に改良された乳化タイプの養毛化粧料が
得られることを見出し、本発明をなすに至った。As a result of intensive research to achieve the above object, the present inventors found that a fatty acid having an odd carbon chain length or a predetermined derivative thereof, a predetermined cationic surfactant, a predetermined nonionic surfactant, It has been discovered that an emulsified hair-nourishing cosmetic that has an excellent hair-nourishing effect and has significantly improved storage stability at low temperatures can be obtained by combining it with a specified ester oil, and has developed the present invention. I came to do this.
即ち、本発明の毛髪化粧料は、奇数炭素鎖長を有する脂
肪酸またはその所定の誘導体の1種または2種以上を0
.1〜15iJ%と、所定のカチオン界面活性剤の1檀
または2種以上f、0.01〜5重量%と、常温で液体
の分枝鎖長を有するエステル油の1種ま九は2種以上を
1〜30重量%とを含有することを特徴とする。That is, the hair cosmetic of the present invention contains 0 or more fatty acids having odd carbon chain lengths or predetermined derivatives thereof.
.. 1 to 15 iJ%, one or more predetermined cationic surfactants, 0.01 to 5% by weight, and one or two ester oils having a branched chain length that is liquid at room temperature. It is characterized by containing 1 to 30% by weight of the above.
本発明の養毛化粧料に用いらnる奇数炭素鎖長を有する
脂肪酸としては、炭素鎖を構成する炭素原子の数が奇数
のものであれば、その炭素鎖が飽和鎖と不飽和鎖のいず
れであってもよく、不飽和鎖の場合、複数の二重結合を
含んでいてもよい。The fatty acid having an odd carbon chain length used in the hair nourishing cosmetic of the present invention may be one in which the number of carbon atoms constituting the carbon chain is an odd number. Any one may be used, and in the case of an unsaturated chain, it may contain a plurality of double bonds.
炭素鎖長は、好ましくFi、9個以上、更に好ましくは
11〜25個である。そのような脂肪酸としては、例え
ば、ノナン酸、ウンデカン酸、トリデカン酸、ペンタデ
カン酸、ヘプタデカン酸、ノナデカン酸、へ/エイコサ
ン醸、トリコサン酸、ペンタコサン酸などを挙げること
が出来る。The carbon chain length is preferably Fi, 9 or more, more preferably 11 to 25. Examples of such fatty acids include nonanoic acid, undecanoic acid, tridecanoic acid, pentadecanoic acid, heptadecanoic acid, nonadecanoic acid, he/eicosanoic acid, tricosanoic acid, pentacosanoic acid, and the like.
本発明の養毛化粧料に用いられる奇数炭素鎖長を有する
脂肪酸の誘導体としては、下記に示すものが挙げられる
。Examples of the fatty acid derivatives having an odd carbon chain length used in the hair nourishing cosmetic composition of the present invention include those shown below.
イ)下記−紋穴(1)又は〔■〕で示されるモノグリセ
ライド
(1) CH20COR(If) CH2(OH)
CH2(O)f) CH2(OH)ここ
で、Rは偶数の炭素鎖長を有する直鎖式有機基を表わす
。b) Below - Monoglyceride (1) indicated by pattern hole (1) or [■] CH20COR (If) CH2 (OH)
CH2(O)f) CH2(OH) where R represents a linear organic group with an even carbon chain length.
口)下記−紋穴CI)又は(IV)で示さnるジグリセ
ライド
〔鳳)
(IDここで、R1及びR2の少なくともいずnか一方
は偶数の炭素鎖長を有する直鎖式有機基を表わす。R1
又1iR2のいずれか一方が偶数の炭素鎖長を有する鎖
式有機基であればこの発明の効果は得らn、他の一方は
奇数の炭素鎖長を有する鎖式有機基であってもよい。し
かしながら、奇数鎖長の脂肪酸のジグリセライドである
ことが特に好ましい。) Diglyceride indicated by the following - Monana CI) or (IV) [Otori]
(ID Here, at least one of R1 and R2 represents a linear organic group having an even carbon chain length. R1
Further, if either one of 1iR2 is a chain organic group having an even number of carbon chain lengths, the effects of the present invention will not be obtained, but the other one may be a chain organic group having an odd number of carbon chain lengths. . However, diglycerides of fatty acids of odd chain length are particularly preferred.
ハ)下記−紋穴(V)で示されるトリグリセライド(V
) CH20COR。C) Below - triglyceride (V) indicated by the hole (V)
) CH20COR.
CH2COR2 CH20COR。CH2COR2 CH20COR.
ここで、R,、R,2及びR3のうち少なくとも1つは
偶数の炭素鎖長を有する直鎖式有機基を表わす。R,、
R2及びR3のうち少なくともいずれか1つが偶数の炭
素鎖長を有する鎖式有機基であればこの発明の効果は得
られ、他のものは奇数の炭素鎖長を有する鎖式有機基で
あってもかまわない。しかしながら、奇数鎖長の脂肪酸
のトリグリセライドが特に好ましい。Here, at least one of R,, R, 2 and R3 represents a linear organic group having an even number of carbon chain lengths. R,,
The effects of the present invention can be obtained if at least one of R2 and R3 is a chain organic group having an even number of carbon chain lengths, and the other is a chain organic group having an odd number of carbon chain lengths. I don't mind. However, triglycerides of fatty acids of odd chain length are particularly preferred.
二)下記−紋穴(Vl)で表わされる脂肪酸塩〔■1〕
(RCOO)M
ここで、RVi偶数の炭素鎖長を有する直鎖式有機基、
Mは金属原子、nはMの価数に対応した整数を表わす。2) The following - Fatty acid salt represented by Monka (Vl) [■1] (RCOO)M where RVi is a linear organic group having an even carbon chain length,
M represents a metal atom, and n represents an integer corresponding to the valence of M.
代表的なものはRCOONa 。A typical example is RCOONa.
RCOOK 、及びRCOOLlなどである。RCOOK, RCOOLl, etc.
ホ)下記−紋穴〔■〕で表わされるエステル〔■〕
RCOOR’
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基、R
′は1価若しくは2価アルコール残基。E) The following - Ester [■] represented by a pattern hole [■] RCOOR' Here, R is a linear organic group having an even number of carbon chain lengths, R
' is a monohydric or dihydric alcohol residue.
アミン残基、ポリオキシエチレン残基、ソルビタン残基
、又はシ雪糖残基を表わす。1価アルコールの典型例は
メタノール及びエタノールであり、アミン残基の典型例
はモノ・ソ・トリエタノールアミンである。Represents an amine residue, polyoxyethylene residue, sorbitan residue, or sucrose residue. Typical examples of monohydric alcohols are methanol and ethanol, and typical examples of amine residues are mono-so-triethanolamine.
へ)下記−紋穴〔lで表わされる第1アミド〔I
RCONR’R’
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基を表
す。R′及びR1は水素又は人体に悪影響を与えること
がない有機基を表わす。f) Below - Primary amide [I RCONR'R' represented by Monna [l] where R represents a linear organic group having an even carbon chain length. R' and R1 represent hydrogen or an organic group that does not adversely affect the human body.
ト)下記−紋穴(K)で表わされる第2アミド(IX)
RC0NC0R2
R′
ここで、R1及びR2のうち少なくともどちらか一方は
偶数の炭素鎖長を有する直鎖式有機基を表わす。R1及
びR2のうち少なくと本一方が偶数鎖長の有機基であれ
ばこの発明の効果を得ることができ、他のもの及びR′
は人体に悪影響を与えないものであればどのような有機
基であってもよい。もっとも、双方とも偶数鎖長の直鎖
式有機基であることが特に好ましい。R′は水素であっ
てもよい。g) Second amide (IX) represented by the following pattern (K) RC0NC0R2 R' Here, at least one of R1 and R2 represents a linear organic group having an even carbon chain length. If at least one of R1 and R2 is an organic group with an even chain length, the effects of the present invention can be obtained;
may be any organic group as long as it does not have an adverse effect on the human body. However, it is particularly preferred that both groups are linear organic groups with even chain lengths. R' may be hydrogen.
チ)下記−紋穴(X)で表わされる第3アミド(X) RlCONCOR。h) The following - tertiary amide (X) represented by Monna (X) RlCONCOR.
COR。C.O.R.
ここで、 R,、R2及びR3のうち少なくとも1つは
偶数の炭素鎖長を有する直鎖式有機基を表わす。R1,
R,及びR5のうち少なくと411つが偶数鎖長の有機
基であればこの発明の効果を得ることができ、他のもの
は人体に悪影II’を与えないものであればどのような
有機基であってもよい。Here, at least one of R,, R2 and R3 represents a linear organic group having an even carbon chain length. R1,
The effect of the present invention can be obtained if at least 411 of R and R5 has an even chain length, and the others can be any organic group as long as it does not give an adverse effect II' on the human body. It may be a base.
もつとも、これら3つともが偶数鎖長の直鎖式有機基で
あることが特に好ましい。However, it is particularly preferable that all three of these groups are straight-chain organic groups with even chain lengths.
す)下記−紋穴(XI)で表わされる二塩基酸及びその
塩
(刺
HOOCRCOOH
ここで、Rは奇数の炭素鎖長含有する直鎖式有機基を表
わす。) Dibasic acids and their salts represented by the following - HOOCRCOOH (XI) Here, R represents a linear organic group containing an odd number of carbon chain lengths.
ヌ)下記−紋穴〔刈〕で表わされるステロールエステル
〔刈〕
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基を表
わす。n) Below - Sterol ester represented by Monana [Kari] [Kari] Here, R represents a linear organic group having an even carbon chain length.
ル)下記−紋穴〔■〕で表わされるリン脂質〔■〕 CH20COR。) Below - Phospholipid represented by a hole [■] [■] CH20COR.
■
CH2COR2
ここで、R1及びR2は鎖式有機基であって、これらの
うち少なくともいずれか一方、特に好ましく拡双方とも
偶数の炭素鎖長を有する直鎖式有機基を表わす。Xはコ
リン残基、エタノールアミン残基、セリン残基、又はイ
ンシトール残基を表わす。Xがコリン残基のときはフす
スファチジルコリン、エタノールアミン残基のときはフ
ォス7アチジルエタノールアミン、セリン残基のときは
フtスファチジルセリン、イノシトールのときはフ中ス
ファチゾルイノシトールとなる。(2) CH2COR2 Here, R1 and R2 are chain organic groups, and at least one of them, particularly preferably both, represents a straight chain organic group having an even number of carbon chain lengths. X represents a choline residue, an ethanolamine residue, a serine residue, or an insitol residue. When X is a choline residue, it is phosphatidylcholine, when it is an ethanolamine residue, it is phosphatidylethanolamine, when it is a serine residue, it is phosphatidylserine, and when it is inositol, it is phosphatidylserine. It becomes sol-inositol.
ッ)下記−紋穴〔畢〕で表わされるフtス7アチジン酸 (XIV) CH20COR。d) Below - Fusu 7 atidic acid represented by a pattern hole [畢] (XIV) CH20COR.
ここで、R1及びR2は鎖式有機基であって、これらの
うち少なくともどちらか一方、%に好ましくけ双方とも
偶数の炭素鎖長を有する直鎖式有機基を表わす。Here, R1 and R2 are chain organic groups, and at least one of them is preferably a straight chain organic group having an even number of carbon chain lengths.
ワ)下記−紋穴(XV)で表わされるスフィンゴ脂質(
XV)
HNH
−O
ここで、Rは偶数の炭素鎖長を有する直鎖式有機基、X
は糖残基、リン酸残基、又はプリン若しくはエタノール
アミンのようなアミン塩基残基を表わす。W) Below - Sphingolipid (
XV) HNH -O where R is a linear organic group with an even carbon chain length,
represents a sugar residue, a phosphate residue, or an amine base residue such as a purine or ethanolamine.
本発明の養毛化粧料における奇数炭素鎖長を有する脂肪
酸又はその誘導体の配合量は、0.1〜15.0重fチ
であシ、好ましくは0.5〜5重量%である。配合量が
0.1重量%未満では、養毛効果が低下し、15.0重
量est−越えると、低温での保存安定性が低下するの
で、好ましくない。The amount of the fatty acid or derivative thereof having an odd carbon chain length in the hair nourishing cosmetic composition of the present invention is 0.1 to 15.0% by weight, preferably 0.5 to 5% by weight. If the amount is less than 0.1% by weight, the hair-nourishing effect will decrease, and if it exceeds 15.0% by weight, storage stability at low temperatures will decrease, which is not preferable.
本発明の養毛化粧料に用いられるカチオン界面活性剤は
、下記に示すものである。The cationic surfactants used in the hair nourishing cosmetic composition of the present invention are shown below.
イ)下記−紋穴(X■)で示される化合物(但し、R1
は炭素数8〜22のアルキル基又はヒドロキンアルキル
基、R2及びR3はそれツレ炭素数1〜3のアルキル基
、炭素数1〜3のヒドロキシアルキル基又はベンノル基
を表わす。b) Compound shown below - Monka (X■) (However, R1
represents an alkyl group having 8 to 22 carbon atoms or a hydroquinalkyl group, and R2 and R3 each represent an alkyl group having 1 to 3 carbon atoms, a hydroxyalkyl group having 1 to 3 carbon atoms, or a benyl group.
RAはR4又はR2と同一の置換基のいずれかを示す。RA represents either the same substituent as R4 or R2.
Xはハロダン原子又は炭素数1〜3のアルキル基を有す
るモノアル午ル硫酸基を示す。)口)下記−紋穴〔罵〕
で示される化合物(但し、R51R61R,のうち2つ
又は3つは炭素数8〜20のアルキル基、残シはメチル
基、エチル基又はヒドロキシエチル基、nは3〜10の
整数、X2はへロrン原子、メチル硫酸基又はエチル硫
酸基を示す。)
ハ)下記−紋穴〔」で示される化合物
・・・・・・〔′A/[l
(但し、R8は炭素数10〜22のアルキル基、R7は
炭素数2〜22のアルキル基を示す。)゛ 上記式〔劇
〕で表わされる化合物の具体例として、セチルトリメチ
ルアンモニウムクロライド、セトステアリルトリメチル
アンモニウムクロライド、ステアリルトリメチルアンモ
ニウムクロライド、エイコシルトリメチルアンモニウム
クロライド、ベヘニルトリメチルアンモニウムクロライ
ド、エイコシルジメチルアンモニウムクロライド、ステ
アリルベンジルアンモニウムクロライド、ベヘニルツメ
チルベンノルアンモニウムクロライド等を挙げることが
出来る。X represents a halodane atom or a monoalkaline sulfate group having an alkyl group having 1 to 3 carbon atoms. ) Mouth) Below - Monana [expletive]
A compound represented by (Represents a ron atom, methyl sulfate group, or ethyl sulfate group.) C) Compounds represented by the following - Monana [''...['A/[l (However, R8 has 10 to 22 carbon atoms. R7 represents an alkyl group having 2 to 22 carbon atoms.) Specific examples of compounds represented by the above formula include cetyltrimethylammonium chloride, cetostearyltrimethylammonium chloride, stearyltrimethylammonium chloride, eiko Examples include siltrimethylammonium chloride, behenyltrimethylammonium chloride, eicosyldimethylammonium chloride, stearylbenzylammonium chloride, and behenyltrimethylbennolammonium chloride.
また、上記式〔罵〕で表わされる化合物の具体例として
、ゾステアリルーリエテノキシメチルアンモニウムハラ
イド、ゾ/やルミチルポリエテノキシエチルアンモニウ
ムハライド、ジノ9ルミチルポリエテノキシヒドロキシ
エチルアンモニウムハライド、トリステアリルポリエテ
ノキシアンモニウムハライド、ジステアリルポリエテノ
キシエチルアンモニウムエチルサルフェート等を挙げる
ことが出来る。In addition, specific examples of the compound represented by the above formula [expletive] include zostearylliethenoxymethylammonium halide, zo/yalumitylpolyethenoxyethylammonium halide, dino9lumitylpolyethenoxyhydroxyethylammonium halide, Examples include stearylpolyethenoxyammonium halide, distearylpolyethenoxyethylammonium ethyl sulfate, and the like.
更に、上記式〔罵〕で表わされる化合物の具体例トシテ
、Nα−ココイル−L−アルギニンエチルエステル−D
L−1:’ロリドンカル?ン[i[、Nα−ココイル−
L−アルギニンメチルエステル−DL−ピロリドンカル
?ン酸塩、Nα−ミリストイル−L−アルギニンエチル
エステル−DL −ヒロリドンカルゲン[i、Nα−/
4ルミトイルーし一アルギニンエチルエステルーDL−
に’ロリドンカルゴン酸塩、Nα−ステアロイルーL−
アルイニンエチルエステルーDL−ビロリドンカルデン
酸塩等を挙げることが出来る。Furthermore, specific examples of the compound represented by the above formula [expletive] Toshite, Nα-cocoyl-L-arginine ethyl ester-D
L-1: 'Lori Donkar? N[i[, Nα-cocoyl-
L-arginine methyl ester-DL-pyrrolidonecar? Nα-myristoyl-L-arginine ethyl ester-DL-hyloridonecalgen [i, Nα-/
4-lumitoyl-1-arginine ethyl ester-DL-
ni' lolidone cargonate, Nα-stearoyl L-
Examples include alinine ethyl ester-DL-pyrrolidone caldate.
本発明の養毛化粧料におけるカチオン界面活性剤の配合
量は、0,01〜5.0道址愛であり、好ましくは0.
1〜1.2重量%である。配合量が0.01it’i%
未滴では、低温での保存安定性が低下し、ま7’c5.
O[[を越えても同様に、低温での保存安定性が低下す
るので、好ましくない。The blending amount of the cationic surfactant in the hair nourishing cosmetic of the present invention is 0.01 to 5.0%, preferably 0.01 to 5.0%.
It is 1 to 1.2% by weight. The blending amount is 0.01it'i%
If left undropped, the storage stability at low temperatures will decrease, and 7'c5.
Exceeding O[[ is also undesirable since storage stability at low temperatures decreases.
本発明の養毛化粧料に用いられる、常温で液体の分枝を
有するエステル油としては、例えば、ミリスチン酸イン
グロビル、パルミチン酸インfロビル、カプロン酸イン
グロビル、カプリル酸インンロピル、カブリン酸イング
ロビル、ラウリン酸イソプロピル、ステアリン酸イング
ロビル、ペトロセリン酸イングロビル、ペトロセリン酸
イソアミル、オレイン酸イソグロビル、オレイン酸イソ
ブチル、オレイン酸イソアミル、エライジン酸イングチ
ル、リシノール酸インブチル、ミリスチン酸イントリデ
シル、ミリスチン酸オクチルドデレル等を挙げることが
出来、こnらの1fl!又は2種以上を用いることが出
来る。Examples of branched ester oils that are liquid at room temperature and used in the hair-growth cosmetics of the present invention include inglovir myristate, inflovir palmitate, inglovir caproate, inthropil caprylate, inglovir cabrate, and lauric acid. Examples include isopropyl, inglovir stearate, inglovil petroselate, isoamyl petroselate, isoglobil oleate, isobutyl oleate, isoamyl oleate, ingtyl elaidate, inbutyl ricinoleate, intridecyl myristate, octyl doderel myristate, etc. Ra's 1fl! Or two or more types can be used.
本発明の養毛化粧料におけるエステル油の配合itは、
1〜30重量%であυ、好ましくは5〜20重f%であ
る。配合量が1重量−未満では、低温での保存安定性が
低下し、30重量%を越えても同様に、低温での保存安
定性が低下するので、好ましくない。The formulation of ester oil in the hair nourishing cosmetic of the present invention is as follows:
The content is 1 to 30% by weight, preferably 5 to 20% by weight. If the blending amount is less than 1% by weight, the storage stability at low temperatures will decrease, and if it exceeds 30% by weight, the storage stability at low temperatures will similarly decrease, which is not preferable.
本発明の養毛化粧料においては、グリセリン骨格を有す
る非イオン界面活性剤、例えば、/ IJオ午ジエチレ
ン硬化ヒマシ油、ポリオ中ジエチレン硬化ヒマシ油イン
ステアレート、ポリオ、キシエチレングリセリルモノス
テアレート、デカグリセリルモノステアレート、ヘキテ
グリセリルモノオレエート、ポリオキシエチレンソルビ
ットテトラオレエート、4リオキシエチレングリセリル
トリイソステアレート、ポリオΦジエチレングリセリル
トリオレエート、ポリオキシエチレン硬化ヒマシ油モノ
ラウレート、ホリオキシエチレン硬化ヒマシ油モノイン
ステアレート等の1種又は2種以上を配合することが好
ましい。In the hair nourishing cosmetic composition of the present invention, a nonionic surfactant having a glycerin skeleton, for example, diethylene hydrogenated castor oil, diethylene hydrogenated castor oil in polio, polio, xyethylene glyceryl monostearate, Decaglyceryl monostearate, hexiteglyceryl monooleate, polyoxyethylene sorbittetraoleate, 4-lyoxyethylene glyceryl triisostearate, polyΦ diethylene glyceryl trioleate, polyoxyethylene hydrogenated castor oil monolaurate, phorioxy It is preferable to blend one or more types of ethylene hydrogenated castor oil monoinstearate and the like.
本発明の養毛化粧料における非イオン界面活性剤の配合
量は、0.1〜15.0重fチが好ましく、更に好まし
くは0.3〜5重量%である。The blending amount of the nonionic surfactant in the hair nourishing cosmetic composition of the present invention is preferably 0.1 to 15.0% by weight, more preferably 0.3 to 5% by weight.
本発明の養毛化粧料に対しては、更に補助成分として、
慣用の種々のもの、例えばエステル類、多価アルコール
、界面活性剤、油脂類等を配合することが出来る。また
、薬効成分としてビタミン類、ホルモン類、アミノ酸類
、血管拡張剤、抗炎症剤、細胞賦活剤、角質溶解剤、殺
菌剤、経皮吸収促進剤などの既知の養毛剤をも同時に配
合し得る。The hair nourishing cosmetic of the present invention further includes, as an auxiliary ingredient,
Various commonly used substances such as esters, polyhydric alcohols, surfactants, oils and fats, etc. can be blended. In addition, known hair nourishing agents such as vitamins, hormones, amino acids, vasodilators, anti-inflammatory agents, cell activators, keratolytic agents, bactericidal agents, and transdermal absorption enhancers may also be incorporated as medicinal ingredients.
[効果]
本発明の養毛化粧料は、優れた養毛効果を有するととも
に、低温安定性において著しく改善されている。[Effect] The hair nourishing cosmetic composition of the present invention has an excellent hair nourishing effect and is significantly improved in low temperature stability.
[実施例コ
以下に、本発明の実施例と比較例とを示し、本発明の効
果をよシ具体的に説明する。なお、各側の説明に先だっ
て、各側で採用した養毛効果試験法および低温安定性の
評価法について説明する。[Example] Examples and comparative examples of the present invention will be shown below to specifically explain the effects of the present invention. Before explaining each side, the hair growth effect test method and low-temperature stability evaluation method adopted by each side will be explained.
(養毛効果試験法)
体f[約2.5.Fのニエージーランドホワイト種ウサ
ギ6〜8羽を一群とし、背部を除毛し、休止期にあるも
ののみを実験に供した。休止期にあるものの除毛した背
部に被験試料を各0.2 ratづつ、週2回、30〜
60日間噴霧し、休止期毛が成長期毛に変換するのに要
する日数を調べた。なお、養毛効果の指標として用いた
「促進日数」とは、被験物質を含まないエタノールを噴
霧した場合に比べて、休止期毛から成長期毛への変換が
、何日促進されたかを示すものである。養毛効果は、下
記第1表に示す基準に基づき評価した。(Hair nourishing effect test method) Body f [approx. 2.5. A group of 6 to 8 F New Zealand White rabbits was prepared, the hair on the back was removed, and only those in the resting phase were used for the experiment. 0.2 rats each of the test sample was applied to the hair-removed backs of animals in the telogen phase, twice a week for 30~
The product was sprayed for 60 days, and the number of days required for telogen hair to convert into anagen hair was determined. The "days of promotion" used as an index of hair growth effect indicates how many days the conversion from telogen hair to anagen hair is promoted compared to spraying ethanol that does not contain the test substance. It is something. The hair growth effect was evaluated based on the criteria shown in Table 1 below.
(低温安定性評価方法)
被験試料約50gを透明がラスびんに取シ、−5℃の高
温槽に保存して1ケ月経過後、室温に復元して、乳化状
態を観察し、判定する。(Low-temperature stability evaluation method) Approximately 50 g of the test sample is placed in a transparent glass bottle, stored in a high-temperature tank at -5°C for one month, and then returned to room temperature to observe and judge the emulsification state.
○・・・変化なし
△・・・やや変化あり
×・・・凝集または分離などの変化あシ下記第2表〜第
5表に示す28種の試験試料を調製し、そnぞnについ
てその特性を評価した。○...No change △...Slight change ×...Changes such as aggregation or separation 28 types of test samples shown in Tables 2 to 5 below were prepared, and the Characteristics were evaluated.
その結果を同表に示す。The results are shown in the same table.
第2表〜第5表から、本発明の範囲内の有効成分を含む
試験試料(実施例1〜23)は、いずれも優れた特性を
示しているのに対し、本発明の範囲外の有効成分を含む
試験試料(比較例1〜5)は、いずnも優nfc特性を
示していないことがわかる。From Tables 2 to 5, it can be seen that the test samples (Examples 1 to 23) containing active ingredients within the scope of the present invention all showed excellent properties, while those containing active ingredients outside the scope of the present invention It can be seen that none of the test samples containing the components (Comparative Examples 1 to 5) exhibited superior NFC characteristics.
次に、本発明の養毛化粧料を、実際の種々の製品に適用
した処方例を示す。いずれの例においても優れた特性を
示すことが確認されている。Next, examples of formulations in which the hair nourishing cosmetic composition of the present invention is applied to various actual products will be shown. It has been confirmed that all examples exhibit excellent properties.
処方例1(育毛剤)
モニウムクロライド I
POE(20)硬化ヒマシ油 1酢酸dt−
α−トコフェロ
ール 0.2パルミチン酸
イングロビル 7.0バントテニルエチルエーテ
ル 0.3エチニルエストラジオール 0.
0004サフラワー油 0.3ビオ
チン 0.02センブリ抽出(
−スト 0.1ヒノキチオール
0.05コハク酸 0.
5番 料 0.599
.5%エタノール 5.ONI製水
残部処方例2(ヘアトニック)
ニクムクロライド 0.5グリセリルモ
ノステアレート0.5
ミリスチy酸イソプロピル 7.0イングロビル
メチルフエノール 0.05t−メントール
02ニコチン酸ベンジル 0.
003香 料 0
.595%エタノール 5.0精製水
残部処方例3(ヘアリ中ツ
ド)
セトステアリルメチルアン
モニウムクロライド 0.5POE(20
)硬化ヒマシ油 0.5ノぐルミチン酸イノグ
ロビル 7.070二ECW
0.14リオギシグロピレンプチル
エーテル 15.0香 料
0.5961%エタノー
ル 5.0精製水
残部処方例4(エアゾール育毛剤)
[0液]配合成分 重量%
アンモニウムクロライド 0.5POE(15
)グリセリルモノ
ステアレート0.5
ミリスチン酸イングロビル 7.0クエン酸
0.3t−メントール
0.1ビオチy 0
.02香料 0.5
エタノール 5.0精製水
残部(充填用稀釈液)
原液 35
フロン114 45Formulation example 1 (hair growth agent) Monium chloride I POE (20) Hydrogenated castor oil 1acetic acid dt-
α-Tocopherol 0.2 Inglovir palmitate 7.0 Bantothenyl ethyl ether 0.3 Ethinyl estradiol 0.
0004 Safflower oil 0.3 Biotin 0.02 Aspergillus extract (
-St 0.1 hinokitiol
0.05 Succinic acid 0.
No. 5 fee 0.599
.. 5% ethanol 5. ONI water
Remaining formulation example 2 (hair tonic) Nicum chloride 0.5 Glyceryl monostearate 0.5 Isopropyl myristate 7.0 Inglovil methylphenol 0.05 t-menthol
02 Benzyl Nicotinate 0.
003 fragrance 0
.. 595% ethanol 5.0 Purified water
Remaining formulation example 3 (Hairy Nakatsudo) Cetostearylmethylammonium chloride 0.5POE (20
) Hydrogenated castor oil 0.5 no glumitate inoglovir 7.0702 ECW
0.14 Liogishiguropyrenebutyl ether 15.0 Fragrance
0.5961% ethanol 5.0 Purified water
Remaining formulation example 4 (aerosol hair growth agent) [0 liquid] Ingredients Weight% Ammonium chloride 0.5 POE (15
) Glyceryl monostearate 0.5 Inglovir myristate 7.0 Citric acid
0.3t-menthol
0.1biochiy 0
.. 02 Fragrance 0.5 Ethanol 5.0 Purified water
Remainder (diluent for filling) Stock solution 35 Freon 114 45
Claims (1)
1種または2種以上を0.1〜15重量%と、カチオン
界面活性剤の1種または2種以上を0.01〜5重量%
と、常温で液体の分枝鎖長を有するエステル油の1種ま
たは2種以上を1〜30重量%とを含有することを特徴
とする養毛化粧料。(1) 0.1 to 15% by weight of one or more fatty acids or derivatives thereof having an odd carbon chain length, and 0.01 to 5% by weight of one or more cationic surfactants.
and 1 to 30% by weight of one or more ester oils having branched chain lengths that are liquid at room temperature.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29084987A JPH01132511A (en) | 1987-11-18 | 1987-11-18 | Hair tonic cosmetic |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29084987A JPH01132511A (en) | 1987-11-18 | 1987-11-18 | Hair tonic cosmetic |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH01132511A true JPH01132511A (en) | 1989-05-25 |
Family
ID=17761278
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29084987A Pending JPH01132511A (en) | 1987-11-18 | 1987-11-18 | Hair tonic cosmetic |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH01132511A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002017863A1 (en) * | 2000-08-31 | 2002-03-07 | Shiseido Co., Ltd. | Hair growers |
WO2006114140A1 (en) * | 2005-04-27 | 2006-11-02 | Beiersdorf Ag | Pristanic acid-containing cosmetic preparations |
-
1987
- 1987-11-18 JP JP29084987A patent/JPH01132511A/en active Pending
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2002017863A1 (en) * | 2000-08-31 | 2002-03-07 | Shiseido Co., Ltd. | Hair growers |
WO2006114140A1 (en) * | 2005-04-27 | 2006-11-02 | Beiersdorf Ag | Pristanic acid-containing cosmetic preparations |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5561264B2 (en) | Hair growth composition | |
JPS5927809A (en) | Hair tonic | |
JPH0892011A (en) | Deodorizing make-up goods | |
JPH0826957A (en) | Compounding agent of deodorizing active compound based on alpha, omega-alkane dicarboxylic acid and oligoglycerol monocarboxylate ester | |
JPS6115815A (en) | Cosmetic for hair | |
JP4940527B2 (en) | Sustainable hair growth composition | |
JPS62135409A (en) | Hair tonic cosmetic | |
US6548557B1 (en) | Neutralization of phosphate esters, compositions based upon and methods using same | |
JPH01132511A (en) | Hair tonic cosmetic | |
JPH07316022A (en) | Hair tonic | |
WO2005030152A1 (en) | Hair tonic composition | |
JP2004155690A (en) | Hair tonic composition | |
KR960000393B1 (en) | Composition for preventing graying of the hair | |
JP4304394B2 (en) | Hair restorer composition | |
JP2594553B2 (en) | Hair cosmetics | |
JP2522482B2 (en) | Hair restorer | |
JPH0225400B2 (en) | ||
JP2000001423A (en) | Oil solution for cosmetic and cosmetic | |
JP2994484B2 (en) | Hair cosmetics | |
EP0435180B1 (en) | Composition for treating hair | |
JP2528661B2 (en) | Hair restorer | |
JP7346838B2 (en) | External pharmaceutical composition | |
US20030118618A1 (en) | New Method for making a water-in-oil emulsion | |
JP2021123587A (en) | Pharmaceutical composition for external use | |
JP2021167298A (en) | Pharmaceutical composition for external use |